Monday, 16 November 2026Follow on 𝕏

Markets

Markets

BioMarin shares slip as pipeline update fails to impress

Shares in BioMarin Pharmaceutical (BMRN) are under pressure as investors react to a scientific update that focuses on early-stage and investigational data rather than near-term commercial catalysts. The imaging results for Voxzogo in…

Markets

ADARx jumps in Nasdaq debut after upsized IPO

Shares in ADARx Pharmaceuticals (ADRX) rose 30 per cent above their offer price in Nasdaq debut trading after the late-stage gene therapy developer raised $446.3mn in an upsized US initial public offering.